Nicholas Naclerio has been named VP of corporate development at Illumina. Naclerio formerly was co-founder and executive chairman of Quanterix. In the new role, he will be responsible for licensing, strategic planning, and acquisitions. He also previously raised money for Boreal Genomics, O-Link Bioscience, and Fluxion Bioscience, and he served as president and CEO of ParAllele BioScience.
William Shanahan has retired from the board of directors of Life Technologies to have time to pursue other matters. He will continue to consult for the company. Shanahan had been a member of the board since 2008.